Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alphatec Holdings, Inc. Director's Dealing 2021

Jun 16, 2021

31614_dirs_2021-06-16_8e96a8d1-293e-4819-8023-88d993cc3b36.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alphatec Holdings, Inc. (ATEC)
CIK: 0001350653
Period of Report: 2021-06-16

Reporting Person: L-5 Healthcare Partners, LLC (10% Owner, Director by deputization)
Reporting Person: Segal Paul (10% Owner, Director by deputization)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-16 Common Stock M 400000 $3.50 Acquired 8336508 Direct
2021-06-16 Common Stock F 93747 $14.93 Disposed 8242761 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-06-16 Warrants to Purchase Common Stock $3.50 M 400000 Acquired 2023-05-17 Common Stock (400000) Direct

Footnotes

F1: Each of Jason Hochberg and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.

F2: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

F3: Represents a "cashless exercise" of outstanding warrants. The reporting person received 306,253 shares of Common Stock on cashless exercise of warrants to purchase 400,000 shares of Common Stock. The Company withheld 93,747 shares of Common Stock underlying the warrants for payment of the exercise price, using the VWAP on June 15, 2021 of $14.93, pursuant to the terms of the warrant.